Ligand validation:4YZX

MRD: (4R)-2-METHYLPENTANE-2,4-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4YZX_MRD_A_208	85%	67%	0.089	0.954	0.39	0.87	-	-	0	0	100%	1
4YZX_MRD_A_209	40%	56%	0.16	0.871	0.56	1.11	-	-	8	0	100%	0.35
4YZA_MRD_A_208	97%	60%	0.056	0.972	0.37	1.15	-	1	0	0	100%	0.91
4YZ0_MRD_A_211	92%	56%	0.077	0.967	0.64	1.05	-	1	0	0	100%	0.87
3T9G_MRD_A_202	79%	51%	0.089	0.935	0.6	1.26	-	2	0	0	100%	1
4Z05_MRD_B_204	71%	47%	0.098	0.919	0.63	1.39	-	2	0	0	100%	1
7EK9_MRD_A_201	97%	88%	0.06	0.977	0.29	0.38	-	-	0	0	100%	1
4MKN_MRD_A_306	97%	67%	0.068	0.98	0.4	0.85	-	-	0	0	100%	0.5
3GZB_MRD_G_156	96%	70%	0.066	0.973	0.43	0.73	-	-	0	0	100%	1
1SWU_MRD_A_1	94%	66%	0.067	0.967	0.41	0.88	-	1	0	0	100%	1
3RY1_MRD_A_4005	92%	74%	0.082	0.974	0.34	0.67	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.